نتایج جستجو برای: ribavirin

تعداد نتایج: 6051  

Journal: :Molecular pharmacology 2006
Pieter Leyssen Erik De Clercq Johan Neyts

The precise mechanism by which the broad-spectrum anti-RNA virus agent ribavirin elicits its in vitro antiviral effect has remained a matter of debate. We have demonstrated that inhibition of cellular inosine monophosphate dehydrogenase (IMPDH) activity, and thus depletion of intracellular GTP pools, is the predominant mechanism by which ribavirin inhibits the replication of four flavi- and two...

Journal: :Journal of hepatology 2015
Donald Jensen Kenneth E Sherman Christophe Hézode Stanislas Pol Stefan Zeuzem Victor de Ledinghen Albert Tran Magdy Elkhashab Ziad H Younes Marcelo Kugelmas Stefan Mauss Gregory Everson Velimir Luketic John Vierling Lawrence Serfaty Maurizia Brunetto Jeong Heo David Bernstein Fiona McPhee Delphine Hennicken Patricia Mendez Eric Hughes Stephanie Noviello

BACKGROUND & AIMS Improved therapies for peginterferon/ribavirin null or partial responders are needed. This study evaluated daclatasvir (NS5A inhibitor) and asunaprevir (NS3 protease inhibitor) plus peginterferon alfa-2a and ribavirin in this patient population. METHODS This open-label, phase 3 study (HALLMARK-QUAD; NCT01573351) treated patients with chronic hepatitis C virus (HCV) genotype ...

Journal: :Antiviral therapy 2012
Sheeja M Krishnan Narendra M Dixit

BACKGROUND Greater cumulative exposure to ribavirin increases response to interferon-ribavirin combination therapy for hepatitis C but also induces more severe anaemia. Polymorphisms in the ITPA gene protect against ribavirin-induced anaemia. The maximum dosage of ribavirin that can be tolerated by patients with different ITPA polymorphisms remains unknown. METHODS We developed a mathematical...

Journal: :Journal of virology 2013
Dong-Hoon Chung Åke Västermark Jeremy V Camp Ryan McAllister Susanna K Remold Yong-Kyu Chu Carl Bruder Colleen B Jonsson

In vitro, ribavirin acts as a lethal mutagen in Hantaan virus (HTNV)-infected Vero E6 cells, resulting in an increased mutation load and viral population extinction. In this study, we asked whether ribavirin treatment in the lethal, suckling mouse model of HTNV infection would act similarly. The HTNV genomic RNA (vRNA) copy number and infectious virus were measured in lungs of untreated and rib...

Journal: :Lancet 2015
Christophe Hézode Tarik Asselah K Rajender Reddy Tarek Hassanein Marina Berenguer Katarzyna Fleischer-Stepniewska Patrick Marcellin Coleen Hall Gretja Schnell Tami Pilot-Matias Niloufar Mobashery Rebecca Redman Regis A Vilchez Stanislas Pol

BACKGROUND Hepatitis C virus (HCV) genotype 4 accounts for about 13% of global HCV infections. Because interferon-containing treatments for genotype 4 infection have low efficacy and poor tolerability, an unmet need exists for effective all-oral regimens. We examined the efficacy and safety of an all-oral interferon-free regimen of ombitasvir, an NS5A inhibitor, and paritaprevir (ABT-450), an N...

2009
Ozlen Atug Hakan Akin Yesim Ozen Alahdab Berrin Ceyhan Nurdan Tozun Osman Ozdogan

Interstitial pneumonitis is a rare but potentially fatal side effect occurring from 2 weeks to 16 weeks after the initiation of treatment with pegylated interferon alpha and ribavirin for chronic hepatitis C.Herein, we present a 68-year-old man with chronic hepatitis C virus infection who developed interstitial pneumonitis association with pegylated interferon after 36 weeks initiation of pegyl...

Journal: :Annals of internal medicine 2015
Mehdi Najafzadeh Karin Andersson William H Shrank Alexis A Krumme Olga S Matlin Troyen Brennan Jerry Avorn Niteesh K Choudhry

BACKGROUND New regimens for hepatitis C virus (HCV) have shorter treatment durations and increased rates of sustained virologic response compared with existing therapies but are extremely expensive. OBJECTIVE To evaluate the cost-effectiveness of these treatments under different assumptions about their price and efficacy. DESIGN Discrete-event simulation. DATA SOURCES Published literature...

بافنده , یوسف, باقری لنکرانی , کامران, صابری فیروزی , مهدی,

Background and purpose: About 200,000 of Iranian population are infected with Hepatitis C Virus. On the basis of Iranian consensus on management of chronic hepatitis C (CHC) infection in 2004, combination therapy with conventional α-Interferon (IFN) plus Ribavirin is the first therapeutic choice in CHC patients. Data are limited on treatment response rate in most areas of the country. To asse...

Journal: :Folia morphologica 2005
K Narayana Urban J A D'Souza Prashanthi Narayan Ganesh Kumar

The present study was planned to evaluate the toxic effects of ribavirin on the reproductive parameters in the male Wistar rat. Rats (11--13 weeks old) were treated with 5 injections (i.p.) of 20, 100 or 200 mg/kg/day ribavirin at intervals of 24 h. The testes were processed for histopathological analysis on days 14, 35, 70 and 105 after the last exposure. The parameters studied were body weigh...

2014
Chunjian Zhao Shuaihua Liu Chunying Li Lei Yang Yuangang Zu

In this study, epigallocatechin gallate (EGCG) palmitate was synthesized and its anti-porcine reproductive and respiratory syndrome virus (PRRSV) activity was studied. Specifically, EGCG palmitate was evaluated for its ability to inhibit PRRSV infection in MARC-145 cells when administered as pre-, post-, or co-treatment. EGCG and ribavirin were used as controls. The results showed that a 50% cy...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید